Cornell University researchers have developed a nonhormonal male contraceptive that proved 100% effective, safe, reversible, and long-acting in a six-year proof-of-principle study conducted in mice. The contraceptive works by targeting a natural checkpoint in meiosis, the process by which sex cells reproduce, safely stopping sperm production without hormonal intervention. Published in the Proceedings of the National Academy of Sciences, the results represent what researchers consider significant progress toward the holy grail of male contraception—a safe, reversible, long-acting nonhormonal option. The breakthrough addresses a major gap in contraceptive choices available to men.
Story comments
Loading comments…